The origin of pre-eclampsia: From decidual " hyperoxia" to late hypoxia

Medical Hypotheses

Volumn 75, Issue 1, 2010, Pages 38-46

  Tranquilli, Andrea L ^a   Landi, Beatrice ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE; HYPOXIA INDUCIBLE FACTOR; LEPTIN; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

AEROBIC METABOLISM; ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD FLOW VELOCITY; CAUSAL ATTRIBUTION; CELL DIFFERENTIATION; DECIDUALIZATION; FIRST TRIMESTER PREGNANCY; GENE FUNCTION; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; HYPEROXIA; HYPOXIA; ISCHEMIA; MATERNAL BLOOD; NONHUMAN; OXIDATIVE STRESS; OXYGEN TENSION; PATHOPHYSIOLOGY; PHENOTYPE; PREECLAMPSIA; REGULATORY MECHANISM; REPERFUSION INJURY; SMOKING; SYNCYTIOTROPHOBLAST; TROPHOBLAST; UPREGULATION;

ANOXIA; CARBON MONOXIDE; FEMALE; HUMANS; HYPEROXIA; LEPTIN; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; SMOKING;

EID: 77953356222     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.01.024     Document Type: Article

References (195)

1. Roberts J.M., Lain K.Y. Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002, 23:359-372.
2. Walker J.J. Pre-eclampsia. Lancet 2000, 356:1260-1265.
3. Redman C.W., Sargent I.L. Placental debris, oxidative stress and pre-eclampsia. Placenta 2000, 21:597-602.
4. Brosens I.A., Robertson W.B., Dixon H.G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972, 1:177-191.
5. Sibai B., Romero R., Klebanoff M.A., Rice M.M., Caritis S., Lindheimer M.D., et al. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am J Obstet Gynecol 2009, 200:630.e1-630.e8. Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network.
6. Farina A., Sekizawa A., De Sanctis P., Purwosunu Y., Okai T., Cha D.H., et al. Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia. Prenat Diagn 2008, 28:956-961.
7. Jauniaux E., Poston L., Burton G.J. Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006, 12:747-755.
8. Ward K. Searching for genetic factors underlying pre-eclampsia: recent progress and persistent challenges. Minerva Ginecol 2008, 60:399-419. [review].
9. Lachmeijer A.M., Dekker G.A., Pals G., Aarnoudse J.G., ten Kate L.P., Arngrímsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002, 105:94-113. [review].
10. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999, 180:499-506.
11. Landi B., Tranquilli A.L. HELLP syndrome and placental inflammatory pathology. Minerva Ginecol 2008, 60:389-398. [review].
12. Tranquilli A.L., Landi B., Corradetti A., Giannubilo S.R., Sartini D., Pozzi V., et al. Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome. Cytokine 2007, 40:82-88.
13. Brosens J.J., Pijnenborg R., Brosens I.A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 2002, 187:1416-1423.
14. Redman C.W. Current topic: pre-eclampsia and the placenta. Placenta 1991, 12:301-308. [review].
15. Yochim J.M. Development of the progestational uterus: metabolic aspects. Biol Reprod 1975, 12:106-133. [review].
16. Yochim J.M., Mitchell J.A. Intrauterine oxygen tension in the rat during progestation: its possible relation to carbohydrate metabolism and the regulation of nidation. Endocrinology 1968, 83:706-713.
17. Williams M.F. The vascular architecture of the rat uterus as influenced by estrogen and progesterone. Am J Anat 1948, 83:247-307.
18. Mitchell J.A., Yochim J.M. Intrauterine oxigen tension during the estrous cycle in the rat: its relation to uterine respiration and vascular activity. Endocrinology 1968, 83:701-705.
19. Pijnenborg R., Bland J.M., Robertson W.B., Dixon G., Brosens I. The pattern of interstitial trophoblast invasion of the myometrium in early human pregnancy. Placenta 1981, 2:303-316.
20. Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust NZ J Obstet Gynaecol 2006, 46:266-273.
21. Rodesch F., Simon P., Donner C., Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992, 80:283-285.
22. Jaffe R., Jauniaux E., Hustin J. Maternal circulation in the first-trimester human placenta-myth or reality?. Am J Obstet Gynecol 1997, 176:695-705. [review].
23. Hustin J., Schaaps J.P. Echographic and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am J Obstet Gynecol 1987, 157:162-168.
24. Genbacev O. To proliferate or to divide - to be or not to be. Early Pregn 2001, 5:63-64.
25. Isaka K., Usuda S., Ito H., Sagawa Y., Nakamura H., Nishi H., et al. Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts. Placenta 2003, 24:53-64.
26. Jones R.L., Findlay J.K., Farnworth P.G., Robertson D.M., Wallace E., Salamonsen L.A. Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology 2006, 147:724-732.
27. Jauniaux E., Gulbis B., Burton G.J. The human first trimester gestational sac limits rather than facilitates oxygen transfer to the fetus - a review. Placenta 2003, 24:S86-S93.
28. Ramsey EM, Donner MW. Placental vasculature and circulation. Anatomy, physiology, radiology, clinical aspects, atlas and textbook. Georg Thieme Stuttgart; 1980. 101 pp.
29. Schaaps J.P., Hustin J., Lambotte R. Utero-placental circulation. J Gynecol Obstet Biol Reprod 1985, 14:395-396.
30. Burton G.J., Jauniaux E., Watson A.L. Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy; the Boyd Collection revisited. Am J Obstet Gynecol 1999, 181:718-724.
31. James J.L., Stone P.R., Chamley L.W. The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Hum Reprod Update 2006, 12:137-144.
32. Graham C.H., Postovit L.M., Park H., Canning M.T., Fitzpatrick T.E. Adriana and Luisa Castellucci award lecture 1999: role of oxygen in the regulation of trophoblast gene expression and invasion. Placenta 2000, 21:443-450.
33. Achiron R., Levran D., Sivan E., Lipitz S., Dor J., Mashiach S. Endometrial blood flow response to hormone replacement therapy in women with premature ovarian failure: a transvaginal Doppler study. Fertil Steril 1995, 63:550-554.
34. Steer C.V., Campbell S., Tan S.L., Crayford T., Mills C., Mason B.A., et al. The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril 1992, 57:372-376.
35. Tekay A., Mamkainen H., Jouppila P. Blood flow changes in uterine and ovarian vasculature, and predictive value of transvaginal pulsed colour Doppler ultrasonography in an in-vitro fertilisation programme. Hum Reprod 1995, 10:688-693.
36. Aytoz A., Ubaldi F., Tournaye H., Nagy Z.P., Van Steirteghem A., Devroey P. The predictive value of uterine artery blood flow measurements for uterine receptivity in an intracytoplasmic sperm injection program. Fertil Steril 1997, 68:935-937.
37. Zaidi J., Campbell S., Pitroff R., Tan S.L. Endometrial thickness, morphology, vascular penetration and velocimetry in predicting implantation in an in vitro fertilisation programme. Ultrasound Obstet Gynecol 1995, 6:191-198.
38. Schild R.L., Holthaus S., d'Alquen J., Fimmers R., Dorn C., van Der Ven H., et al. Quantitative assessment of subendometrial blood flow by three-dimensional-ultrasound is an important predictive factor of implantation in an in-vitro fertilization programme. Hum Reprod 2000, 15:89-94.
39. Brosens J.J., Parker M.G., McIndoe A., Pijnenborg R., Brosens I.A. A role for menstruation in preconditioning the uterus for successful pregnancy. Am J Obstet Gynecol 2009, 200:1-6.
40. Finn C.A. Why do women menstruate? Historical and evolutionary review. Eur J Obstet Gynecol Reprod Biol 1996, 70:3-8.
41. Craven C.M., Morgan T., Ward K. Decidual spiral artery remodeling begins before cellular interaction with cytotrophoblasts. Placenta 1998, 19:241-252.
42. Hendrickson M.R., Kempson R.L. Surgical pathology of the uterine corpus. Major Probl Pathol 1979, 12:1-580.
43. Kearns M., Lala P.K. Life history of decidual cells: a review. Am J Reprod Immunol 1983, 3:78-82.
44. Genbacev O., Joslin R., Damsky C.H., Polliotti B.M., Fisher S.J. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996, 97:540-550.
45. Semenza G.L., Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992, 12:5447-5454.
46. 2 tension. Proc Natl Acad Sci USA 1995, 92:5510-5514.
47. Kieran M.W., Folkman J., Heymach J. Angiogenesis inhibitors and hypoxia. Nat Med 2003, 9:1104.
48. Folkman J. Angiogenesis inhibitors: a new class of drugs. Cancer Biol Ther 2003, 2:S127-133. [review].
49. Maxwell P. HIF-1: an oxygen response system with special relevance to the kidney. J Am Soc Nephrol 2003, 14:2712-2722.
50. Freeburg P.B., Abrahamson D.R. Hypoxia-inducible factors and kidney vascular development. J Am Soc Nephrol 2003, 14:2723-2730. [review].
51. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
52. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 2002, 64:993-998.
53. Semenza G.L., Agani F., Feldser D., Iyer N., Kotch L., Laughner E., et al. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 2000, 475:123-130.
54. Grosfeld A., Turban S., André J., Cauzac M., Challier J.C., Hauguel-de Mouzon S., et al. Transcriptional effect of hypoxia on placental leptin. FEBS Lett 2001, 502:122-126.
55. Rajakumar A., Brandon H.M., Daftary A., Ness R., Conrad K.P. Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta 2004, 25:763-769.
56. Caniggia I., Grisaru-Gravnosky S., Kuliszewski M., Post M., Lye S.J. Inhibition of TGFbeta 3 restores the invasive capacity of extravillous trophoblasts in pre-eclamptic pregnancies. J Clin Invest 1999, 103:1641-1650.
57. Caniggia I., Mostachfi H., Winter J., Gassmann M., Lye S.J., Kuliszewski M., et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta 3. J Clin Invest 2000, 105:577-587.
58. Caniggia I., Winter J.L. Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies - a review. Placenta 2002, 23:S47-S57. [review].
59. Simpson H., Robson S.C., Bulmer J.N., Barber A., Lyall F. Transforming growth factor beta expression in human placenta and placental bed during early pregnancy. Placenta 2002, 23:44-58.
60. Rajakumar A., Michael H.M., Daftary A., Jeyabalan A., Gilmour C., Conrad K.P. Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins. Placenta 2008, 29:290-299.
61. Rockwell L.C., Vargas E., Moore L.G. Human physiological adaptation to pregnancy: inter- and intraspecific perspectives. Am J Hum Biol 2003, 15:330-341.
62. Tissot van Patot M.C., Bendrick-Peart J., Beckey V.E., Serkova N., Zwerdlinger L. Greater vascularity, lowered HIF-1/DNA binding, and elevated GSH as markers of adaptation to in vivo chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 2004, 287:525-532.
63. Mayhew T.M. Changes in fetal capillaries during preplacental hypoxia: growth, shape remodelling and villous capillarization in placentae from high-altitude pregnancies. Placenta 2003, 24:191-198.
64. Tissot van Patot M., Grilli A., Chapman P., Broad E., Tyson W., Heller D.S., et al. Remodelling of uteroplacental arteries is decreased in high altitude placentae. Placenta 2003, 24:326-335.
65. Zamudio S. The placenta at high altitude. High Alt Med Biol 2003, 4:171-191. [review].
66. Moore L.G., Shriver M., Bemis L., Hickler B., Wilson M., Brutsaert T., et al. Maternal adaptation to high-altitude pregnancy: an experiment of nature - a review. Placenta 2004, 25:60-71. [review].
67. Reshetnikova O.S., Burton G.J., Milovanov A.P. Effects of hypobaric hypoxia on the fetoplacental unit: the morphometric diffusing capacity of the villous membrane at high altitude. Am J Obstet Gynecol 1994, 171:1560-1565.
68. Haider D.G., Bucek R.A., Giurgea A.G., Maurer G., Glogar H., Minar E., et al. PGE1 analog alprostadil induces VEGF and eNOS expression in endothelial cells. Am J Physiol Heart Circ Physiol 2005, 289:H2066-2072.
69. Folkman J., Shing Y. Angiogenesis. J Biol Chem 1992, 267:10931-10934. [review].
70. Gordon J.D., Shifren J.L., Foulk R.A., Taylor R.N., Jaffe R.B. Angiogenesis in the human female reproductive tract. Obstet Gynecol Surv 1995, 50:688-697.
71. Risau W. Mechanisms of angiogenesis. Nature 1997, 368:671-674. [review].
72. Ahmed A., Dunk C., Ahmad S., Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) and soluble Flt-1 by oxygen: a review. Placenta 2000, 21:S16-24. [review].
73. Sugimoto H., Hamano Y., Charytan D., Cosgrove D., Kieran M., Sudhakar A., et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003, 278:12605-12608.
74. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
75. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683.
76. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003, 9:677-684. [review].
77. Shore V.H., Wang T.H., Wang C.L., Torry R.J., Caudle M.R., Torry D.S. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997, 18:657-665.
78. Cooper J.C., Sharkey A.M., Charnock-Jones D.S., Palmer C.R., Smith S.K. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1996, 103:1191-1196.
79. Tranquilli A.L., Bezzeccheri V., Giannubilo S.R., Scagnoli C., Mazzanti L., Garzetti G.G. Amniotic vascular endothelial growth factor (VEGF) and nitric oxide (NO) in women with subsequent preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004, 113:17-20.
80. Kingdom J.C., Kaufmann P. Oxygen and placental vascular development. Adv Exp Med Biol 1999, 474:259-275.
81. Challier J.C., Uzan S. The human placenta and its pathologies: focus on oxygen. Med Sci (Paris) 2003, 19:1111-1120. [review].
82. Krebs C., Macara L.M., Leiser R., Bowman A.W., Greer I.A., Kingdom J.C. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 1996, 175:1534-1542.
83. Kaufmann P., Luckhardt M., Schweikhart G., Cantle S.J. Cross-sectional features and three-dimensional structure of human placental villi. Placenta 1987, 8:235-247.
84. Redman C.W., Sargent I.L. Placental stress and pre-eclampsia: a revised view. Placenta 2009, 30:S38-42.
85. Ahmad S., Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004, 95:884-891.
86. Blouin C.C., Pagé E.L., Soucy G.M., Richard D.E. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 2004, 103:1124-1130.
87. Görlach A., Bonello S. The cross-talk between NF-κB and HIF-1: further evidence for a significant liaison. Biochem J 2008, 412:e17-e19.
88. Taylor C.T. Interdependent roles for hypoxia inducible factor and nuclear factor-κB in hypoxic inflammation. J Physiol 2008, 586:4055-4059.
89. van Uden P., Kenneth N.S., Rocha S. Regulation of hypoxia-inducible factor-1alpha by NF-κB. Biochem J 2008, 412:477-484.
90. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453:807-811.
91. Hung T.H., Burton G.J. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006, 45:189-200. [review].
92. Bloxam D.L., Bullen B.E., Walters B.N., Lao T.T. Placental glycolysis and energy metabolism in preeclampsia. Am J Obstet Gynecol 1987, 157:97-101.
93. Xiong X., Demianczuk N.N., Buekens P., Saunders L.D. Association of preeclampsia with high birth weight for age. Am J Obstet Gynecol 2000, 183:148-155.
94. Arias F., Rodriquez L., Rayne S.C., Kraus F.T. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993, 168:585-591.
95. Kim Y.M., Chaiworapongsa T., Gomez R., Bujold E., Yoon B.H., Rotmensch S., et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002, 187:1137-1142.
96. Halliwell B., Gutteridge J.M. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 1995, 18:125-126.
97. Halliwell B., Gutteridge J.M. Oxygen is a toxic gas-an introduction to oxygen toxicity and reactive oxygen species. Free radicals in biology and medicine 1999, 1-35. Oxford University Press, Oxford. B. Halliwell, J.M. Gutteridge (Eds.).
98. Burton G.J., Hempstock J., Jauniaux E. Oxygen, early embryonic metabolism and free radical-mediated embryopathies. Reprod Biomed Online 2003, 6:84-96. [review].
99. Watson A.L., Palmer M.E., Jauniaux E., Burton G.J. Variations in expression of copper/zinc superoxide dismutase in villous trophoblast of the human placenta with gestational age. Placenta 1997, 18:295-299.
100. Watson A.L., Skepper J.N., Jauniaux E., Burton G.J. Changes in concentration, localization and activity of catalase within the human placenta during early gestation. Placenta 1998, 19:27-34.
101. Jauniaux E., Burton G.J. Pathophysiology of histological changes in early pregnancy loss. Placenta 2005, 26:114-123.
102. Jauniaux E., Hempstock J., Greenwold N., Burton G.J. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003, 162:115-125.
103. Jauniaux E., Watson A.L., Burton G.J. Evaluation of respiratory gases and acid-base gradients in fetal fluids and uteroplacental tissue between 7 and 16 weeks. Am J Obstet Gynecol 2001, 184:998-1003.
104. Jauniaux E., Watson A.L., Hempstock J., Bao Y.P., Skepper J.N., Burton G.J. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000, 157:2111-2122.
105. Roberts J.M., Hubel C.A. Is oxidative stress the link in the two-stage model of preeclampsia?. Lancet 1999, 354:788-789.
106. Hubel C.A., Roberts J.M., Taylor R.N., Musci T.J., Rogers G.M., McLaughlin M.K. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 1989, 161:1025-1034.
107. Wang Y., Walsh S.W., Guo J., Zhang J. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol 1991, 165:1695-1700.
108. Uotila J.T., Tuimala R.J., Aarnio T.M., Pyykkö K.A., Ahotupa M.O. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br J Obstet Gynaecol 1993, 100:270-276.
109. Endresen M.J., Tøsti E., Heimli H., Lorentzen B., Henriksen T. Effects of free fatty acids found increased in women who develop pre-eclampsia on the ability of endothelial cells to produce prostacyclin, cGMP and inhibit platelet aggregation. Scand J Clin Lab Invest 1994, 54:549-557.
110. Walsh S.W., Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 1995, 80:1888-1893.
111. Myatt L., Rosenfield R.B., Eis A.L.W., Brockman D.E., Greer I., Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 1996, 28:488-493.
112. Poranen A.K., Ekblad U., Uotila P., Ahotuba M. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta 1996, 17:401-405.
113. Wang Y., Walsh S.W. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta 1998, 19:581-586.
114. Staff A.C., Ranheim T., Khoury J., Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol 1999, 180:587-592.
115. Many A., Hubel C.A., Fisher S.J., Roberts J.M., Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000, 156:321-331.
116. Wang Y., Walsh S.W. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in preeclampsia. Placenta 2001, 22:206-212.
117. Zusterzeel P.L.M., Rutten H., Roelofs H.M.J., Peters W.H.M., Steegers E.A.P. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta 2001, 22:213-219.
118. Vanderlelie J., Venardos K., Clifton V.L., Gude N.M., Clarke F.M., Perkins A.V. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 2005, 26:53-58.
119. Emanuelli M., Sartini D., Rossi V., Corradetti A., Landi B., Vianna C.R., et al. Alpha-hemoglobin-stabilizing protein (AHSP) in hemolysis, elevated liver enzyme, and low platelet (HELLP) syndrome, intrauterine growth restriction (IUGR) and fetal death. Cell Stress Chaperones 2008, 13:67-71.
120. Collard C.D., Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001, 94:1133-1138.
121. Vaage J., Valen G. Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. A review. Scand J Thorac Cardiovasc Surg Suppl 1993, 41:1-18. [review].
122. Schachter M., Foulds S. Free radicals and the xanthine oxidase pathway. Ischaemia-reperfusion injury 1999, 137-147. Blackwell, London. P.A. Grace, R.T. Mathie (Eds.).
123. Hung T.H., Skepper J.N., Burton G. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001, 159:1031-1043.
124. Hubel C.A. Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin Perinatol 1998, 16:75-92.
125. Garzetti G.G., Tranquilli A.L., Cugini A.M., Mazzanti L., Cester N., Romanini C. Altered lipid composition, increased lipid peroxidation, and altered fluidity of the membrane as evidence of platelet damage in preeclampsia. Obstet Gynecol 1993, 81:337-340.
126. Davidge S.T., Hubel C.A., Brayden R.D., Capeless E.C., McLaughlin M.K. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 1992, 79:897-901.
127. Hempstock J., Jauniaux E., Greenwold N., Burton G.J. The contribution of placental oxidative stress to early pregnancy failure. Hum Pathol 2003, 34:1265-1275.
128. Allaire A.D., Ballenger K.A., Wells S.R., McMahon M.J., Lessey B.A. Placental apoptosis in preeclampsia. Obstet Gynecol 2000, 96:271-276.
129. Ishihara N., Matsuo H., Murakoshi H., Laoag-Fernandez J.B., Samoto T., Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002, 186:158-166.
130. Leung D.N., Smith S.C., To K.F., Sahota D.S., Baker P.N. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001, 184:1249-1250.
131. Crocker I.P., Cooper S., Ong S.C., Baker P.N. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003, 162:637-643.
132. Soleymanlou N., Wu Y., Wang J.X., Todros T., Ietta F., Jurisicova A., et al. A novel Mtd splice isoform is responsible for trophoblast cell death in pre-eclampsia. Cell Death Differ 2005, 12:441-452.
133. Jurisicova A., Detmar J., Caniggia I. Molecular mechanisms of trophoblast survival: from implantation to birth. Birth Defects Res C Embryo Today 2005, 75:262-280.
134. Soleymanlou N., Jurisicova A., Wu Y., Chijiiwa M., Ray J.E., Detmar J., et al. Hypoxic switch in mitochondrial myeloid cell leukemia factor-1/Mtd apoptotic rheostat contributes to human trophoblast cell death in preeclampsia. Am J Pathol 2007, 171:496-506.
135. Bainbridge S.A., Sidle E.H., Smith G.N. Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses 2005, 64:17-27.
136. Bainbridge S.A., Smith G.N. HO in pregnancy. Free Radic Biol Med 2005, 38:979-988.
137. Lain K.Y., Powers R.W., Krohn M.A., Ness R.B., Crombleholme W.R., Roberts J.M. Urinary cotinine concentration confirms the reduced risk of preeclampsia with tobacco exposure. Am J Obstet Gynecol 1999, 181:1192-1196.
138. Baum M., Schiff E., Kreiser D., Dennery P.A., Stevenson D.K., Rosenthal T., et al. End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol 2000, 183:900-903.
139. Kreiser D., Baum M., Seidman D.S., Fanaroff A., Shah D., Hendler I., et al. End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia. J Perinatol 2004, 24:213-217.
140. Christova T., Diankova Z., Setchenska M. Heme oxygenase-carbon monoxide signalling pathway as a physiological regulator of vascular smooth muscle cells. Acta Physiol Pharmacol Bulg 2000, 25:9-17.
141. Vreman H.J., Mahoney J.J., Stevenson D.K. Carbon monoxide and carboxyhemoglobin. Adv Pediatr 1995, 42:303-334.
142. Ryter S.W., Otterbein L.E. Carbon monoxide in biology and medicine. Bioessays 2004, 26:270-280.
143. Lyall F., Barber A., Myatt L., Bulmer J.N., Robson S.C. Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J 2000, 14:208-219.
144. Lyall F. Development of the utero-placental circulation: the role of carbon monoxide and nitric oxide in trophoblast invasion and spiral artery transformation. Microsc Res Tech 2003, 60:402-411.
145. Bainbridge S.A., Belkacemi L., Dickinson M., Graham C.H., Smith G.N. Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Am J Pathol 2006, 169:774-783.
146. Knight M., Redman C.W., Linton E.A., Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 1998, 105:632-640.
147. Tenhunen R., Marver H.S., Schmid R. Microsomal heme oxygenase: characterization of the enzyme. J Biol Chem 1969, 244:6388-6394.
148. Keyse S.M., Tyrrell R.M. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA 1989, 86:99-103.
149. Duckers H.J., Boehm M., True A.L., Yet S.F., San H., Park J.L., et al. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 2001, 7:693-698.
150. Melo L.G., Agrawal R., Zhang L., Rezvani M., Mangi A.A., Ehsan A., et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 2002, 105:602-607.
151. Katori M., Anselmo D.M., Busuttil R.W., Kupiec-Weglinski J.W. A novel strategy against ischemia and reperfusion injury: cytoprotection with heme oxygenase system. Transpl Immunol 2002, 9:227-233.
152. Zhang X., Shan P., Jiang D., Noble P.W., Abraham N.G., Kappas A., et al. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 2004, 279:10677-10684.
153. Tsuchihashi S., Fondevila C., Kupiec-Weglinski J.W. Heme oxygenase system in ischemia and reperfusion injury. Ann Transplant 2004, 9:84-87. [review].
154. Ahmed A., Rahman M., Zhang X., Acevedo C.H., Nijjar S., Rushton I., et al. Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 2000, 6:391-409.
155. Levine R.J., Lam C., Qian C., Yu K.F., Maynard S.E., Sachs B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006, 355:992-1005.
156. Cudmore M., Ahmad S., Al-Ani B., Fujisawa T., Coxall H., Chudasama K., et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 2007, 115:1789-1797.
157. Coburn R.F. Mechanisms of carbon monoxide toxicity. Prev Med 1979, 8:310-322.
158. Piantadosi C.A. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic Biol Med 2008, 45:562-569.
159. Raine-Fenning N.J., Campbell B.K., Kendall N.R., Clewes J.S., Johnson I.R. Quantifying the changes in endometrial vascularity throughout the normal menstrual cycle with three-dimensional power Doppler angiography. Hum Reprod 2004, 19:330-338.
160. Cinti S., Frederich R.C., Zingaretti M.C., De Matteis R., Flier J.S., Lowell B.B. Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. Endocrinology 1997, 138:797-804.
161. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-431.
162. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996, 382:250-252.
163. Henson M.C., Castracane V.D., Edwards D.E. Leptin: from satiety signal to reproductive regulator. Leptin and reproduction 2003, 3-11. Kluwer Academic Press/Plenum Press Publishers, New York. M.C. Henson, V.D. Castracane (Eds.).
164. Moschos S., Chan J.L., Mantzoros C.S. Leptin and reproduction: a review. Fertil Steril 2002, 77:433-444. [review].
165. Masuzaki H., Ogawa Y., Sagawa N., Hosoda K., Matsumoto T., Mise H., et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997, 3:1029-1033.
166. Señarís R., Garcia-Caballero T., Casabiell X., Gallego R., Castro R., Considine R.V., et al. Synthesis of leptin in human placenta. Endocrinology 1997, 138:4501-4504.
167. Linnemann K., Malek A., Sager R., Blum W.F., Schneider H., Fusch C. Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab 2000, 85:4298-4301.
168. Lepercq J., Challier J.C., Guerre-Millo M., Cauzac M., Vidal H., Hauguel-de Mouzon S. Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab 2001, 86:2409-2413.
169. Coya R., Gualillo O., Pineda J., Garcia M.C., Busturia M.A., Aniel-Quiroga A., et al. Effect of cyclic 3', 5'-adenosine monophosphate, glucocorticoids, and insulin on leptin messenger RNA levels and leptin secretion in cultured human trophoblast. Biol Reprod 2001, 65:814-819.
170. Gonzalez R.R., Caballero-Campo P., Jasper M., Mercader A., Devoto L., Pellicer A., et al. Leptin and leptin receptor are expressed in the human endometrium and endometrial leptin secretion is regulated by the human blastocyst. J Clin Endocrinol Metab 2000, 85:4883-4888.
171. Craig J.A., Zhu H., Dyce P.W., Wen L., Li J. Leptin enhances porcine preimplantation embryo development in vitro. Mol Cell Endocrinol 2005, 229:141-147.
172. Castellucci M., De Matteis R., Meisser A., Cancello R., Monsurro V., Islami D., et al. Leptin modulates extracellular matrix molecules and metalloproteinases: possible implications for trophoblast invasion. Mol Hum Reprod 2000, 6:951-958.
173. Malik N.M., Carter N.D., Murray J.F., Scaramuzzi R.J., Wilson C.A., Stock M.J. Leptin requirement for conception, implantation, and gestation in the mouse. Endocrinology 2001, 142:5198-5202.
174. Gonzalez R.R., Devoto L., Campana A., Bischof P. Effects of leptin, interleukin-1α, interleukin-6, and transforming growth factor-β on markers of trophoblast invasive phenotype: integrins and metalloproteinases. Endocrine 2001, 15:157-164.
175. Dominguez F., Pellicer A., Simon C. Paracrine dialogue in implantation. Mol Cell Endocrinol 2002, 186:175-181. [review].
176. Cervero A., Horcajadas J.A., Martin J., Pellicer A., Simon C. The leptin system during human endometrial receptivity and preimplantation development. J Clin Endocrinol Metab 2004, 89:2442-2451.
177. Cervero A., Horcajadas J.A., Dominguez F., Pellicer A., Simon C. Leptin system in embryo development and implantation: a protein in search of a function. Reprod Biomed Online 2005, 10:217-223.
178. Yoon S.J., Cha K.Y., Lee K.A. Leptin receptors are down-regulated in uterine implantation sites compared to interimplantation sites. Mol Cell Endocrinol 2005, 232:27-35.
179. Matarese G., Moschos S., Mantzoros C.S. Leptin in immunology. J Immunol 2005, 174:3137-3142.
180. Bouloumié A., Drexler H.C., Lafontan M., Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998, 83:1059-1066.
181. Sierra-Honigmann M.R., Nath A.K., Murakami C., García-Cardeña G., Papapetropoulos A., Sessa W.C., et al. Biological action of leptin as an angiogenic factor. Science 1998, 281:1683-1686.
182. Grosfeld A., Andre J., Hauguel-De Mouzon S., Berra E., Pouyssegur J., Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002, 277:42953-42957.
183. Adali E., Yildizhan R., Kolusari A., Kurdoglu M., Bugdayci G., Sahin H.G., et al. Increased visfatin and leptin in pregnancies complicated by pre-eclampsia. J Matern Fetal Neonatal Med 2009, 22:873-879.
184. Sitras V., Paulssen R.H., Grønaas H., Leirvik J., Hanssen T.A., Vårtun A., et al. Differential placental gene expression in severe preeclampsia. Placenta 2009, 30:424-433.
185. Mumtaz F., Memon A.R., Yousfani S., Tahir S.M., Khushk I., Memon M., et al. Role of serum leptin level as a marker of severity of pre eclampsia. J Ayub Med Coll Abbottabad 2008, 20:13-15.
186. Singh H.J., Abu Bakar A., Che Romli A., Nila A. Raised leptin concentrations in feto-placental tissues from women with preeclampsia. Hypertens Pregn 2005, 24:191-199.
187. Mise H., Sagawa N., Matsumoto T., Yura S., Nanno H., Itoh H., et al. Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J Clin Endocrinol Metab 1998, 83:3225-3229.
188. Iwagaki S., Yokoyama Y., Tang L., Takahashi Y., Nakagawa Y., Tamaya T. Augmentation of leptin and hypoxia-inducible factor 1alpha mRNAs in the pre-eclamptic placenta. Gynecol Endocrinol 2004, 18:263-268.
189. Chan T.F., Su J.H., Chung Y.F., Hsu Y.H., Yeh Y.T., Yuan S.S. Elevated amniotic fluid leptin levels in pregnant women who are destined to develop preeclampsia. Acta Obstet Gynecol Scand 2006, 85:171-174.
190. Tommaselli G.A., Pighetti M., Nasti A., D'Elia A., Guida M., Di Carlo C., et al. Serum leptin levels and uterine Doppler flow velocimetry at 20 weeks gestation as markers for the development of preeclampsia. Gynecol Endocrinol 2004, 19:160-165.
191. Laml T., Preyer O., Hartmann B.W., Ruecklinger E., Soeregi G., Wagenbichler P. Decreased maternal serum leptin in pregnancies complicated by preeclampsia. J Soc Gynecol Investig 2001, 8:89-93.
192. Savvidou M.D., Sotiriadis A., Kaihura C., Nicolaides K.H., Sattar N. Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction. Clin Sci 2008, 115:219-224.
193. Salomon L.J., Benattar C., Audibert F., Fernandez H., Duyme M., Taieb J., et al. Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy. Am J Obstet Gynecol 2003, 189:1517-1522.
194. Clausen T., Djurovic S., Reseland J.E., Berg K., Drevon C.A., Henriksen T. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?. Placenta 2002, 23:380-385.
195. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.